Payer

UnitedHealth Group and Anthem are among 10 companies that get the most "return on leadership," according to Fortune. 

Though healthcare utilization is expected to begin normalizing after pandemic volatility, customer expectations have evolved, and health plans have a lot of work to do to increase their satisfaction, according to J.D. Power's 2022 Commercial Member Health Plan study.

Anthem's chief information officer, Anil Bhatt, is working with Google Cloud to create a synthetic data platform that will help the company detect fraudulent claims and provide more personalized care to members, according to The Wall Street Journal.

U.S. Solicitor General Elizabeth Prelogar told Supreme Court justices that a case asking whether payers and pharmacy benefit managers face Employee Retirement Income Security Act liability when negotiating drug prices doesn't merit review, Bloomberg reported May 25. 

Medicare Advantage enrollment saw major growth across the insurance industry in the first quarter of 2022 and over the last year. Now, payers are making plans to increase that growth even further.

Friday Health Plans Management Services Co., a Denver-based health insurance holding company, has raised $120 million in funding to primarily offer its health plans in new Affordable Care Act marketplaces.

A federal judge in California has approved a class-action settlement requiring Anthem Blue Cross to reprocess claims for eating disorder treatments or pay up to $5,500 for denied claims, Bloomberg reported May 25. 

Bipartisan legislation was introduced May 24 in the Senate that would allow the Federal Trade Commission to increase drug pricing transparency and suppress pharmacy benefit manager practices such as spread pricing and payment clawbacks.

The American Medical Association criticized the health insurance industry May 24 for what it says are slow or ineffective prior authorization reforms implemented over the last four years, despite payers agreeing to changes aimed at improving care access and efficiency.

From earning a spot on the Fortune 500 to signing definitive agreements to sell Magellan Rx and Pantherx Rare, here are eight headlines about the St. Louis-based payer: